Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study

Onyebuchi Okosieme(Cwm Taf University Health Board), Colin Dayan(University of Birmingham), Mohd Shazli Draman(Nilai University), Lakdasa Premawardhana(Ysbyty Ystrad Fawr), Brian P. Tennant(University College London), Carol Evans(University Hospital of Wales), Peter Taylor(University Hospital of Wales), Daniel Thayer(Swansea University), John H. Lazarus(University Hospital of Wales), Adrian Sayers(University of Bristol), John Geen(University of South Wales), Aaron Chai(Cardiff University), Ishrat Khan(Cardiff University), Robert M. French(University of Bristol)
The Lancet Diabetes & Endocrinology
March 1, 2019
10.1016/s2213-8587(19)30059-2
Cited by 130

Related Papers

Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Sex Ratios
|Cambridge University Press eBooks|2002|633
Antenatal Thyroid Screening and Childhood Cognitive Function
|New England Journal of Medicine|2012|630
How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up
|The Lancet|2019|595